PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.835
https://www.valueinhealthjournal.com/article/S1098-3015(12)00900-X/fulltext
Title : PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00900-X&doi=10.1016/j.jval.2012.03.835
First page : A155
Section Title : Urinary/Kidney Disorders
Open access? : No
Section Order : 323
Categories :
Tags :
Regions :
ViH Article Tags :